EP0707493A4 - Inhibitors and target molecule co-localization - Google Patents
Inhibitors and target molecule co-localizationInfo
- Publication number
- EP0707493A4 EP0707493A4 EP95904785A EP95904785A EP0707493A4 EP 0707493 A4 EP0707493 A4 EP 0707493A4 EP 95904785 A EP95904785 A EP 95904785A EP 95904785 A EP95904785 A EP 95904785A EP 0707493 A4 EP0707493 A4 EP 0707493A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- localization
- inhibitors
- target molecule
- molecule
- target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000008045 co-localization Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/121—Hammerhead
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- AIDS & HIV (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/185,827 US5827935A (en) | 1992-05-27 | 1992-05-27 | Chimeric tRNAlys -ribozyme molecules |
US185827 | 1994-01-24 | ||
PCT/US1994/013798 WO1995019788A1 (en) | 1994-01-24 | 1994-12-02 | Inhibitors and target molecule co-localization |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0707493A1 EP0707493A1 (en) | 1996-04-24 |
EP0707493A4 true EP0707493A4 (en) | 1999-03-31 |
Family
ID=22682602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95904785A Withdrawn EP0707493A4 (en) | 1994-01-24 | 1994-12-02 | Inhibitors and target molecule co-localization |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0707493A4 (en) |
AU (1) | AU692208B2 (en) |
CA (1) | CA2157015A1 (en) |
WO (1) | WO1995019788A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7919583B2 (en) | 2005-08-08 | 2011-04-05 | Discovery Genomics, Inc. | Integration-site directed vector systems |
US8309791B2 (en) | 2008-07-16 | 2012-11-13 | Recombinectics, Inc. | Method for producing a transgenic pig using a hyper-methylated transposon |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0387775A1 (en) * | 1989-03-16 | 1990-09-19 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Genetic construct for inhibiting RNA function |
WO1993023569A1 (en) * | 1992-05-11 | 1993-11-25 | Ribozyme Pharmaceuticals, Inc. | Method and reagent for inhibiting viral replication |
WO1993024133A1 (en) * | 1992-05-27 | 1993-12-09 | City Of Hope | CHIMERIC tRNALYS-RIBOZYME MOLECULES |
-
1994
- 1994-12-02 CA CA002157015A patent/CA2157015A1/en not_active Abandoned
- 1994-12-02 WO PCT/US1994/013798 patent/WO1995019788A1/en not_active Application Discontinuation
- 1994-12-02 EP EP95904785A patent/EP0707493A4/en not_active Withdrawn
- 1994-12-02 AU AU13335/95A patent/AU692208B2/en not_active Expired
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0387775A1 (en) * | 1989-03-16 | 1990-09-19 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Genetic construct for inhibiting RNA function |
WO1993023569A1 (en) * | 1992-05-11 | 1993-11-25 | Ribozyme Pharmaceuticals, Inc. | Method and reagent for inhibiting viral replication |
WO1993024133A1 (en) * | 1992-05-27 | 1993-12-09 | City Of Hope | CHIMERIC tRNALYS-RIBOZYME MOLECULES |
Non-Patent Citations (4)
Title |
---|
HERSCHLAG D ET AL: "AN RNA CHAPERONE ACTIVITY OF NON-SPECIFIC RNA BINDING PROTEINS IN HAMMERHEAD RIBOZYME CATALYSIS", EMBO JOURNAL, vol. 13, no. 12, 15 June 1994 (1994-06-15), pages 2913 - 2924, XP000567895 * |
ROSSI J J ET AL: "RIBOZYMES AS ANTI-HIV-1 THERAPEUTIC AGENTS: PRINCIPLES, APPLICATIONS, AND PROBLEMS", AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 8, no. 2, February 1992 (1992-02-01), pages 183 - 189, XP002026934 * |
See also references of WO9519788A1 * |
SULLENGER B A ET AL: "TETHERING RIBOZYMES TO A RETROVIRAL PACKAGING SIGNAL FOR DESTRUCTION OF VIRAL RNA", SCIENCE, vol. 262, 3 December 1993 (1993-12-03), pages 1566 - 1569, XP000567869 * |
Also Published As
Publication number | Publication date |
---|---|
WO1995019788A1 (en) | 1995-07-27 |
CA2157015A1 (en) | 1995-07-27 |
AU692208B2 (en) | 1998-06-04 |
EP0707493A1 (en) | 1996-04-24 |
AU1333595A (en) | 1995-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL331338A1 (en) | Thiosulphonamidic metaloprotease inhibitors | |
EP0835109A4 (en) | Pyridinone-thrombin inhibitors | |
ZA98376B (en) | Sulfamide-metalloprotease inhibitors | |
PL331900A1 (en) | 1,4-heterocyclic inhibitors of metaloprotease | |
PL331838A1 (en) | 1,3-diheterocyclic inhibitors of metaloproteases | |
PL330120A1 (en) | Farnesilic protein transferase inhibitors | |
GB9611422D0 (en) | Coated scale inhibitors | |
GB2321641B (en) | Sulfamide-metalloprotease inhibitors | |
GB9623908D0 (en) | Amino acid derivatives | |
PL331795A1 (en) | Heterocyclic metaloprotease inhibitors | |
PL330482A1 (en) | Novel amino acid derivatives and their application as thrombosin inhibitors | |
PL328074A1 (en) | Therapeutical method and pharmaceutic composition | |
PL331803A1 (en) | Bidonoric metaloprotease inhibitors | |
HUP9903631A3 (en) | Adhesion inhibitors | |
GB9422952D0 (en) | Corrosion inhibitor | |
ZA988934B (en) | Method and composition for inhibiting corrosion | |
GB9425701D0 (en) | Enzyme inhibitors | |
GB2319530B (en) | Low toxic corrosion inhibitor | |
HU9503783D0 (en) | Squvalen syntetase inhibitors | |
ZA9711548B (en) | Ricin inhibitors and methods for use thereof | |
DE69523450D1 (en) | Inhibitor | |
EP0707493A4 (en) | Inhibitors and target molecule co-localization | |
GB9321917D0 (en) | Corrosion inhibitors | |
GB9311043D0 (en) | Inhibitors of nef-cd4 binding | |
ZA982298B (en) | Metal loss inhibitors and processes therewith |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19950913 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE FR GB |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19990215 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): DE FR GB |
|
17Q | First examination report despatched |
Effective date: 20000524 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20001205 |